Formulation design of ointment base suitable for healing of lesions in treatment of bedsores

被引:12
作者
Shigeyama, M
Ohgaya, T
Takeuchi, H
Hino, T
Kawashima, Y
机构
[1] Takayama Red Cross Hosp, Dept Pharm, Gifu 5068550, Japan
[2] Gifu Pharmaceut Univ, Dept Pharmaceut Engn, Gifu 5028585, Japan
关键词
minocycline hydrochloride; sustained release; hardness; rotation disk method; Franz diffusion cell; hydrophilic polymer;
D O I
10.1248/cpb.49.129
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We intended to develop a desired ointment base suitable for treatment of bedsores including the proliferation of granulation and epidermis. The main bedsore bacteria detected in our hospital were S. aureus in gram-positive coccus and P. aeruginosa in gram-negative bacillus. As the macrogol ointment (MO) was found to have bactericidal effects on these bacteria, MO was adopted as the base for the objective ointment. To improve the properties of the ointment base such as regulating the humidity of the exudation and controlling the release of antibiotics formulated in the ointment, co-formulating effects of various additives to MO were evaluated. The sustained release function of the ointment base was obtained by adding hydrophilic petrolatum (HP) to MO. However, the resultant ointment was found to have a pool humidity regulating property. On the other hand, MO containing 5% of hydroxypropyl cellulose (HPC) showed both the humidity regulating and the controlled drug releasing properties, it was considered that HPC particles dispersed in the ointment could be swelled by absorbing water to form a gel network. The curd tension meter tests for the ointments prepared with the various polymers show ed that the MO-HPC base, which showed the highest sustained drug releasing property, was found to have the highest hardness. This result means that HPC formulated into the base forms the most rigid gel structure to resist the erosion of the ointment and to control the drug release.
引用
收藏
页码:129 / 133
页数:5
相关论文
共 14 条
[1]  
AIDA H, 1999, JSHP, V35, P161
[2]  
[Anonymous], RINSHO IYAKU
[3]  
DVONCH VM, 1992, SURGERY, V112, P18
[4]  
ICHIKAWA H, 1992, PROG MED, V12, P2781
[5]  
Kiyohara Yoshifumi, 1994, Yakuzaigaku, V54, P117
[6]  
KOYAMA H, 1992, KISO TO RINSHOU, V26, P67
[7]  
NAKAJYO M, 1993, MED PHARM, V29, P205
[8]  
NAKAJYO M, 1993, MED PHARM, V29, P197
[9]  
Shigeyama M, 1999, CHEM PHARM BULL, V47, P744
[10]  
SHIGEYAMA M, 1987, KISO TO RINSHOU, V21, P3793